Mai Kadry | Biochemistry | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. Mai Kadry | Biochemistry | Best Researcher Award

Assist. Prof. Dr. Mai Kadry  , NRC , Egypt

Dr. Mai Osman Mohamed Kadry is an Assistant Professor at the Therapeutic Chemistry Department of the National Research Centre in Egypt, specializing in molecular and biochemical research. With over two decades of experience, she has contributed significantly to the advancement of therapeutic chemistry. Dr. Kadry obtained her PhD in Biochemistry from Cairo University in 2016, focusing on oxidative injury mitigation through antioxidants. She has authored and co-authored multiple articles in prestigious journals. Her research is driven by a passion for finding therapeutic solutions to biochemical challenges, with a focus on molecular mechanisms and drug development.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Mai Osman Mohamed Kadry has made significant contributions to the field of therapeutic chemistry, particularly in molecular and biochemical research. As an Assistant Professor at the National Research Centre (NRC), her dedication to scientific advancement is evident in her research on oxidative stress, drug-induced toxicity, and the potential of nanotechnology to mitigate such effects. Her work has been published in high-impact journals, showcasing her expertise in areas like cancer research, biochemistry, and drug development. Additionally, her comprehensive teaching experience in academic settings has strengthened her ability to impart knowledge to the next generation of researchers.

Areas for Improvement:

Although Dr. Kadry’s work is impressive, her research could further benefit from exploring more collaborative projects across different research centers and incorporating a broader range of interdisciplinary approaches. Engaging with cutting-edge technologies such as AI-driven drug discovery or multi-omics data analysis could significantly expand her impact on therapeutic chemistry.

Education:

Dr. Mai Kadry’s academic journey began with a Bachelor’s degree in Pharmaceutical Sciences from Ain Shams University, graduating with honors in 2003. She later pursued an MSc in Pharmaceutical Sciences with a focus on Biochemistry from Helwan University in 2008. Her doctoral research at Cairo University led to a PhD in Biochemistry in 2016, where she studied the amelioration of oxidative stress induced by titanium dioxide nanoparticles in mice. This educational foundation has equipped her with a robust understanding of biochemistry, molecular biology, and drug therapy.

Experience:

Dr. Mai Kadry has a distinguished career at the National Research Centre (NRC) in Egypt, starting as an Assistant Researcher in 2004 and advancing to Assistant Professor in 2021. Over the years, she has contributed to groundbreaking research in therapeutic chemistry, particularly in the area of oxidative stress and drug toxicity. Dr. Kadry has also taught pharmacognosy at the Faculty of Pharmacy, 6 October University, and served on committees focusing on academic development. Her extensive teaching and research experience positions her as a leader in her field.

Research Focus:

Dr. Mai Kadry’s research focuses on therapeutic chemistry, exploring the molecular mechanisms of drug-induced toxicity, oxidative stress, and potential protective treatments. Her work investigates the impact of nanomaterials like titanium dioxide and their effects on cellular pathways. She also studies the synergistic potential of natural compounds to mitigate damage from toxins, using advanced biochemical methods to evaluate their efficacy. Additionally, Dr. Kadry has a keen interest in cancer research, focusing on autophagy signaling and the development of novel drug formulations.

Publications Top Notes:

  • “Titanium nanostructure mitigating doxorubicin-induced testicular toxicity in rats via regulating major autophagy signaling pathways” 🧬💉
  • “Inflammatory mediators-induced DNA damage in liver and brain injury: Therapeutic approach of 5-Methoy-N-acetyltryptamine” 🧠💊
  • “Necroptosis and autophagy in cisplatinum-triggered nephrotoxicity: Novel insights regarding their prognostic and diagnostic potential” 💊🩺
  • “Resveratrol-based nano-formulations as an emerging therapeutic strategy for ovarian carcinoma” 🎗️💡
  • “miR-122-IGF-1R signaling allied through the dysregulated lncRNA MALAT-1 expression in gastric carcinoma” 🧬🦠
  • “Reciprocal crosslink among MeCP2/BDNF/CREB signaling pinpointed in autism spectrum disorder” 🧠🔬
  • “CRISPR-Cas9 genome and long non-coding RNAs as a novel diagnostic index for prostate cancer therapy” 🧬🧬
  • “Collaboration of Hprt/K-RAS/c-Myc mutation in the oncogenesis of T-lymphocytic leukemia” 🩸⚗️
  • “Thioctic acid shield against lipopolysaccharide depression and endoplasmic reticulum stress: GR7M/Homer/ATF6 signaling” 🧬🛡️
  • “Titanium dioxide nanostructure-loaded Adriamycin surmounts resistance in breast cancer therapy” 🧬🎗️

Conclusion:

Dr. Mai Osman Mohamed Kadry stands out as an exemplary researcher in her field. Her focus on therapeutic chemistry, particularly in relation to oxidative stress, toxicity, and nanotechnology, positions her as a promising candidate for the Researcher of the Year Award. Through her continued contributions and potential for further interdisciplinary collaboration, she will likely continue to make pivotal advancements in the field of molecular and biochemical research.

 

 

 

Esmail El-Fakharany | cell biology | Best Researcher Award

Published on by Cell Biologist

Prof. Esmail El-Fakharany | cell biology | Best Researcher Award

Prof. Esmail El-Fakharany  , city of scientific research and technological applications , Egypt

Dr. Tamer Abdelrazik is a distinguished researcher in the field of biological sciences and biotechnology, specializing in microbiology, virology, and the preparation of therapeutic agents. He has contributed significantly to the scientific community with over 102 published papers and 16 book chapters. Dr. Abdelrazik holds an esteemed academic position as a part-time research fellow at Pharos University in Alexandria and the Pharmaceutical and Fermentation Industries Development Centre (PFIDC), Alexandria, Egypt. He is also recognized for his leadership as the principal investigator of several funded research projects, focusing on COVID-19 treatments, cancer therapeutics, and environmental technologies. Dr. Abdelrazik’s academic and research achievements have led to his recognition in Stanford’s ranking of the top 2% of impacting scientists globally.

Publication Profile:

Orcid

Strengths for the Award:

Dr. Tamer Abdelrazik demonstrates exceptional research achievements in the fields of biological sciences, biotechnology, and applied biomedical sciences. His impressive track record includes over 102 journal papers and 16 book chapters, with significant contributions to the understanding of antimicrobial agents, cancer therapies, and novel drug delivery systems. Notably, his leadership on projects like “Lactoferrin-Zinc nanocombinations for COVID-19” reflects his innovative approach in addressing global health challenges. Additionally, his inclusion in Stanford’s top 2% ranking of impacting scientists for 2023 showcases his prominence and impact in scientific research. His high H-index (28) and academic supervision of 9 M.Sc. and 13 Ph.D. students highlight his dedication to advancing research and mentoring future scientists.

Areas for Improvement:

While Dr. Abdelrazik’s research output is impressive, expanding the scope of his studies into other emerging fields such as AI-driven drug discovery or sustainability in biomedical engineering could strengthen his scientific legacy. Further interdisciplinary collaborations could also enhance his research portfolio, bringing new perspectives into his work.

Education:

Dr. Tamer Abdelrazik holds an extensive academic background in biological sciences and biotechnology. His early academic training was conducted at recognized institutions in Egypt, followed by advanced studies leading to multiple degrees in the field of microbiology, immunology, and biochemistry. His educational journey enabled him to hone expertise in molecular biology, protein chemistry, tissue culture, and the study of antiviral and anticancer agents. Throughout his academic tenure, Dr. Abdelrazik demonstrated excellence in both theoretical knowledge and experimental practices, often publishing the outcomes of his studies in high-impact journals. He continues to guide future researchers through his supervision of several MSc and Ph.D. students. His education in both the practical and theoretical aspects of biomedical sciences underpins his success as a prominent researcher in various subfields, including therapeutic protein development and environmental biotechnology.

Experience:

Dr. Tamer Abdelrazik’s professional career spans over 15 years, during which he has built a reputation as a leading researcher in the fields of microbiology, biotechnology, and molecular biology. He started his career as a lab specialist at the National Research Centre, Cairo, where he worked from 2006 to 2011. Since 2023, he has held part-time research fellowships at Pharos University and PFIDC, Alexandria, Egypt. In addition to his research duties, he has served as a mentor, advising 9 MSc and 13 Ph.D. students. Dr. Abdelrazik has been the principal investigator on numerous grant-funded projects, focusing on advanced therapies for cancer, COVID-19, and environmental issues. His innovative work, particularly in the development of antimicrobial filters, nanomedicines, and drug delivery systems, has positioned him as a key figure in both academic and industrial research. His career is marked by constant collaboration with national and international research institutions.

Awards and Honors:

Dr. Tamer Abdelrazik has been recognized for his outstanding contributions to scientific research, especially in the fields of biotechnology and medical sciences. He was awarded the prestigious State Encouragement Award in 2019 by the Egyptian Academy of Science and Technology for his advancements in medical technologies. In 2014, he received a certificate from SRTA-City for his significant research achievements and distinguished publications. More recently, Dr. Abdelrazik was ranked in the top 2% of the most impactful scientists globally by Stanford in 2023. These accolades are a testament to his contributions in developing therapeutic agents, including antiviral and anticancer treatments, and his work in environmental health technologies. Dr. Abdelrazik’s recognition by such esteemed institutions highlights his dedication to advancing scientific knowledge and improving human health. These awards solidify his status as a key figure in his field and underscore his influence on global research.

Research Focus:

Dr. Tamer Abdelrazik’s research primarily focuses on advancing medical biotechnology and environmental technologies. He is particularly known for his work in virology, microbiology, and the development of antiviral agents, with a focus on COVID-19. Additionally, his research addresses cancer therapeutics, especially the formulation of nano-complexes to treat various carcinomas. Dr. Abdelrazik’s work includes the investigation and development of novel bioactive compounds such as antimicrobial agents and the fabrication of therapeutic proteins and enzymes. His ongoing projects also explore environmental applications, such as antimicrobial air filters integrated with air-conditioning systems and water purification membranes. His research aims to merge scientific knowledge with practical solutions to address global health challenges. Moreover, he is dedicated to enhancing the delivery of therapeutic agents through innovative drug delivery systems, with a special emphasis on tissue culture, protein chemistry, and immunology.

Publications Top Notes:

  1. Interaction of Jania rubens Polyphenolic Extract as an Antidiabetic Agent with α-Amylase, Lipase, and Trypsin 🧑‍🔬🍀 (2024)
  2. Influence of Cedar Essential Oil on Polyvinyl Alcohol/Cedar Oil/Kaolin Composite Hydrogels 🌲💧 (2023)
  3. Preparation and Physicochemical Characterization of Gelatin–Aldehyde Derivatives 🧪🧬 (2022)
  4. Fatty N-Hexadecanyl Chitosan Derivatives for Biomedical Applications 🧬💉 (2022)
  5. Development of Polyvinyl Alcohol/Kaolin Sponges for Wound Healing Promotion 💉🌱 (2021)
  6. Green Cation Exchange Membrane Doped with Ceramic Nanotubes for Fuel Cells 🔋🔬 (2021)
  7. Effects of Octenyl Succinic Anhydride on Rice Starch Emulsions 🍚💡 (2020)
  8. Antimicrobial Activity of Modified Aminated Chitosan with Aromatic Esters 🦠🍃 (2019)
  9. Cinnamyl O-amine Functionalized Chitosan for Drug Delivery 💊🌿 (2019)
  10. Development of Polyelectrolyte Membranes for Direct Methanol Fuel Cells 🔋🧪 (2019)
  11. Smart Alginate/Chitosan Microcapsules for Colon-Specific Drug Delivery 💊👨‍🔬 (2019)

Conclusion:

Dr. Abdelrazik’s outstanding academic and research contributions make him a highly deserving candidate for the Research for Best Researcher Award. His consistent achievements in high-impact publications, leadership in research projects, and innovative scientific discoveries have placed him at the forefront of his field, solidifying his reputation as an influential researcher.

 

 

 

Yimin Zhu | Immunology Cellular Interactions | Women Researcher Award

Published on by Cell Biologist

Prof. Yimin Zhu | Immunology Cellular Interactions | Women Researcher Award

Prof. Yimin Zhu , Suzhou Institute of Nanotechnology, Chinese Academy of Sciences , China

Prof. Yimin Zhu is a distinguished researcher in bioengineering, specializing in cancer therapies, biomaterials, and peptide screening platforms. With a background in both clinical medicine and biotechnology, she bridges the gap between medical applications and cutting-edge biotechnological innovations. Prof. Zhu completed her master’s in Clinical Medicine from Tianjin Medical University in 1996 and a Ph.D. in Biochemistry from the National University of Singapore in 2005. She has made significant contributions to cancer immunotherapy, drug delivery systems, and biomarker identification. Prof. Zhu’s work has led to over 30 first-author/co-corresponding publications in leading scientific journals, and she holds more than 20 patents. She currently holds a professorship at Suzhou Institute of Nano-Tech and Nano-Bionics, CAS, where her research continues to advance cancer treatments through novel molecular mechanisms and drug delivery platforms.

Publication Profile:

Scopus

Strengths for the Award:

  1. Interdisciplinary Expertise: Prof. Yimin Zhu has a unique blend of clinical medicine and advanced biotechnology expertise, making her well-suited to bridge the gap between medical practice and cutting-edge cancer research. Her background in both the clinical and research fields allows her to tackle cancer therapies from multiple angles.
  2. Impactful Research: Prof. Zhu’s research focuses on critical areas in cancer therapy, such as peptide-based immunotherapy, tumor mechanisms, drug delivery systems, and biomarker discovery. She has published over 30 high-impact papers in leading journals, showcasing her leadership in the field.
  3. Innovative Contributions: She has made substantial contributions to developing peptide-based bispecific CAR T cells and innovative drug delivery systems, with several patents granted. These innovations hold great promise for advancing cancer therapy and improving patient outcomes.
  4. Support and Funding: Prof. Zhu has successfully secured substantial research funding, including multiple grants from the National Natural Science Foundation of China, supporting her groundbreaking research in cancer immunotherapy and biomaterial development.

Areas for Improvement:

  1. Broader Outreach: Although Prof. Zhu has made impressive advancements in cancer research, expanding her work’s visibility to a broader audience in the medical and biotechnology communities, as well as among the general public, could increase the impact of her innovations.
  2. Collaboration and Mentorship: Further expanding interdisciplinary collaborations, particularly with social scientists or clinicians in oncology, could strengthen the practical application of her research and increase its translation into clinical practice. Additionally, mentoring young women in STEM could increase her contribution to fostering diversity in the field.
  3. Public Engagement: Enhancing communication efforts to present her research in a more accessible format for non-experts could be a significant avenue for impact, particularly in terms of attracting additional funding and public interest in her cancer-focused work.

Education:

Prof. Yimin Zhu’s educational journey reflects her interdisciplinary approach to bioengineering and medical science. She earned her Master’s degree in Clinical Medicine from Tianjin Medical University in 1996, where she initially focused on medical practice, gaining hands-on experience as a resident and consultant in Neurology. Her passion for scientific research led her to pursue a Ph.D. in Biochemistry from the National University of Singapore, completed in 2005. This transition to biochemistry allowed her to explore molecular biology, cancer research, and biotechnology. Prof. Zhu’s postdoctoral work at the University of California, Santa Barbara, in Chemical Engineering, further honed her expertise in nanotechnology, bioengineering, and therapeutic innovations. This broad educational foundation, combining clinical experience with cutting-edge research, has uniquely positioned her as a leader in cancer bioengineering and drug delivery systems.

Experience:

Prof. Yimin Zhu’s diverse experience spans both clinical medicine and high-impact research. Between 1996 and 2000, she worked as a resident and consultant doctor in Neurology, which provided a strong foundation in patient care and medical science. Transitioning to research, she served as a research fellow at the National University of Singapore from 2003 to 2005, focusing on biochemistry and cancer-related molecular mechanisms. Prof. Zhu further developed her expertise during her postdoctoral training in the Chemical Engineering Department at the University of California, Santa Barbara, where she explored the intersection of chemical engineering, nanotechnology, and therapeutic interventions. Since joining the Suzhou Institute of Nano-Tech and Nano-Bionics in 2008, she has been a professor, where she leads innovative research in peptide-based cancer therapies, immunotherapy, and drug delivery systems. Her extensive academic background and practical experience have earned her numerous patents and substantial research funding.

Research Focus:

Prof. Yimin Zhu’s research primarily focuses on bioengineering for cancer treatment, peptide screening platforms, and targeted drug delivery systems. Her work involves identifying molecular mechanisms behind tumor cell behavior and developing innovative methods for cancer diagnosis and therapy. She is dedicated to advancing cancer immunotherapy, particularly through the development of peptide-based bispecific CAR T cells targeting key proteins like EGFR and tumor stroma. Prof. Zhu’s research aims to enhance the efficacy of cancer treatments while minimizing side effects. Her studies also explore the development of smart delivery systems, such as extracellular vesicle-based nanodrugs, to improve the precision and effectiveness of drug delivery to tumor sites. Additionally, her work delves into the identification of cancer biomarkers, offering new ways to predict tumor metastasis and optimize treatment regimens. By combining molecular biology, nanotechnology, and biotechnology, Prof. Zhu’s research holds great promise for advancing personalized cancer care.

Publications Top Notes:

  • The peptide-based bispecific CAR T cells target EGFR and tumor stroma for effective cancer therapy 🧬
  • Develop a PD-1-blockade peptide to reinvigorate T-cell activity and inhibit tumor progress 💉
  • Natural killer cells contribute to ‘hot’ tumor regression in the allergic inflammatory environment 🦠
  • Identification of cancer protein biomarker based on cell specific peptide and its potential role in predicting tumor metastasis 🔬
  • Extracellular Vesicle‐Based Nanodrug Delivery 💊
  • Inhibition of Autophagy Promotes the Elimination of Liver Cancer Stem Cells by CD133 Aptamer-Targeted Delivery of Doxorubicin 🧫
  • Dermatophagoides pteronyssinus allergen Der p 22: Cloning, expression, IgE-binding in asthmatic children, and immunogenicity 🌿
  • Reforming the Chimeric Antigen Receptor by Peptide Towards Optimized CAR T Cells With Enhanced Anti-Cancer Potency and Safety 🦠
  • Smart delivery of poly-peptide composite for effective cancer therapy 💡
  • The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells ⚙️

Conclusion:

Prof. Yimin Zhu’s research excellence, particularly in cancer therapy, peptide-based immunotherapy, and novel drug delivery systems, positions her as a highly deserving candidate for the Research for Women Researcher Award. Her interdisciplinary approach, groundbreaking innovations, and leadership in publishing high-impact scientific papers make her a trailblazer in the field of bioengineering. By addressing the areas for improvement, particularly in outreach and mentorship, Prof. Zhu could amplify her contributions even further, inspiring the next generation of women scientists and advancing the fight against cancer.

 

 

 

Xi Yao | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Dr. Xi Yao | Cancer Cell Biology | Best Researcher Award

Dr. Xi Yao , Yunnan University , China

Xi Yao is a prominent researcher in the field of vertebrate evolutionary biology, specializing in dinosaur studies. Currently based at Yunnan University, Kunming, China, he is affiliated with the Center for Vertebrate Evolutionary Biology. With a background in Geology (Bachelor’s from Northwest University, China), Yao further honed his expertise in Vertebrate Paleontology through his Master’s and Ph.D. from the Institute of Vertebrate Paleontology and Paleoanthropology, Chinese Academy of Sciences. He has actively participated in several fossil excavation projects across China, particularly in Xinjiang, Neimongol, and Yunnan, focusing on Jurassic and Cretaceous dinosaur species. His research contributions have garnered recognition in the scientific community with numerous publications in prestigious journals and an active collaboration with international experts.

Publication Profile:

Orcid

Strengths for the Award:

Xi Yao is a highly accomplished paleontologist with a strong background in dinosaur research, specifically focusing on vertebrate evolution and systematics. His educational journey, from a Geology degree to a Master’s and Ph.D. in Vertebrate Paleontology, reflects his deep-rooted expertise in the field. His active role at Yunnan University has allowed him to contribute significantly to understanding the evolution of dinosaur species, particularly in the Jurassic and Cretaceous periods. Notably, his groundbreaking studies on early Jurassic ornithischian dinosaurs and tyrannosauroid locomotion, coupled with his extensive fieldwork across China, position him as a leading expert in dinosaur paleontology. His collaborations with international researchers, such as Prof. John Hutchinson from the Royal Veterinary College and Prof. Corwin Sullivan from the University of Alberta, strengthen his global presence in the scientific community. His publications in well-regarded journals like iScience, Cretaceous Research, and Elife highlight his impactful contributions.

Areas for Improvement:

While Xi Yao has made substantial contributions to dinosaur paleontology, an area for improvement would be expanding his outreach and professional memberships. Engaging more actively with larger paleontological communities and taking editorial roles in academic journals could further boost his visibility and influence. In addition, he has not published books or patents, which are often essential for showcasing a comprehensive body of work in paleontology.

Education:

Xi Yao completed his Bachelor’s degree in Geology from Northwest University, China, laying a foundation in earth sciences. He furthered his academic career at the Institute of Vertebrate Paleontology and Paleoanthropology (IVPP) of the Chinese Academy of Sciences in Beijing, earning both his Master’s and Ph.D. in Vertebrate Paleontology. During his graduate studies, Yao focused on dinosaur evolution and systematics, particularly the study of fossil evidence and ancient ecosystems. His educational journey reflects a blend of geological and paleontological expertise, which supports his comprehensive research on prehistoric life, including the evolutionary trends in dinosaur species. His work at Yunnan University allows him to continue applying his interdisciplinary knowledge to the study of dinosaur fossils, emphasizing both anatomical and ecological perspectives. His academic achievements also include collaborating with other renowned researchers globally, broadening his scientific impact.

Experience:

Xi Yao has accumulated extensive experience in the field of paleontology through both research and fieldwork. After completing his higher education, he became an integral member of the research community at Yunnan University, where he specializes in vertebrate evolutionary biology, particularly dinosaurs. His fieldwork has taken him to several notable excavation sites across China, including Xinjiang, Neimongol, and Yunnan Province, where he has contributed significantly to discovering and analyzing dinosaur fossils. His ongoing research on tyrannosauroid locomotion and dinosaur evolution is supported by grants from prestigious agencies such as the National Natural Science Foundation of China. He has also forged collaborations with leading paleontologists, such as Prof. John Hutchinson from the Royal Veterinary College in the UK, and Prof. Corwin Sullivan from the University of Alberta, Canada. Xi Yao’s extensive hands-on experience in excavations, along with his academic contributions, make him a valuable figure in his field.

Research Focus:

Xi Yao’s primary research interest lies in dinosaur evolution, with a focus on both Jurassic and Cretaceous species. His work has contributed to the understanding of dinosaur phylogeny, anatomy, and locomotion, particularly through his studies on theropods and ornithischians. One of his significant projects involves studying the locomotion of tyrannosauroids through digital modeling, which explores how these iconic predators moved and interacted with their environment. Additionally, he has reported groundbreaking findings on rare early Jurassic ornithischians in Southern China, making important contributions to the understanding of dinosaur diversity during this period. His studies also extend to the description of new dinosaur species, including oviraptorosaurians, therizinosaurians, and ornithomimosaurians, primarily in the Cretaceous of northern China. This focus on dinosaur systematics not only enriches the scientific community’s understanding of dinosaur lineage but also sheds light on broader evolutionary patterns of life on Earth.

Publications Top Notes:

  • “New evidence for the earliest ornithischian dinosaurs from Asia” 📜 (iScience, 2024)
  • “A new ankylosaurid dinosaur from the Upper Cretaceous of Jiangxi Province, southern China” 🦕 (Historical Biology, 2024)
  • “New ornithomimosaurian pelvis from the Upper Cretaceous Erlian Formation of Nei Mongol, North China” 🦖 (Cretaceous Research, 2022)
  • “A new early branching armored dinosaur from the Lower Jurassic of southwestern China” 🛡️ (Elife, 2022)
  • “A new transitional therizinosaurian theropod from the Early Cretaceous Jehol Biota of China” 🦖 (Scientific Reports, 2019)
  • “Caenagnathasia sp. from the Iren Dabasu Formation of Erenhot, Nei Mongol, China” 🦕 (Vertebrata PalAsiatica, 2015)

Conclusion:

Xi Yao is an exceptional candidate for the Best Researcher Award due to his outstanding contributions to the field of dinosaur evolution and systematics. His research has not only expanded our understanding of dinosaur diversity but has also provided new insights into locomotion and dinosaur phylogeny. His dedication to fieldwork and collaboration with international researchers adds value to his research endeavors. Despite some areas for improvement, such as increased professional memberships and diversification of publications, his overall achievements place him among the top researchers in the field. Therefore, Xi Yao deserves strong consideration for this prestigious award.

 

 

 

Yingrong Du | Liver diseases | Best Researcher Award

Published on by Cell Biologist

Prof. Yingrong Du | Liver diseases | Best Researcher Award

Prof. Yingrong Du , The Third People’s Hospital of Kunming , China

Dr. Du Yingrong is a Chief Physician at Dali University’s Sixth Affiliated Hospital (Kunming Third People’s Hospital), specializing in cardiovascular medicine. With over three decades of experience, Dr. Du has made significant contributions to clinical medicine and healthcare management. He is dedicated to advancing patient care, particularly in cardiovascular health, and is actively involved in several research projects, particularly in the areas of atherosclerosis and chronic non-communicable diseases. Dr. Du has also focused on improving healthcare systems in rural China and addressing public health challenges such as COVID-19. His expertise extends to both clinical work and hospital management

Publication Profile:

Scopus

Strengths for the Award:

Dr. Du Yingrong demonstrates exceptional expertise in both clinical medicine and research, making significant contributions in cardiovascular health, atherosclerosis, and public health. He has a strong academic background with advanced education in Hospital Management and Clinical Medicine. As the Chief Physician at Dali University’s Sixth Affiliated Hospital, he has exhibited leadership in managing cardiovascular care, implementing innovative emergency treatment systems, and addressing healthcare disparities in rural China. Dr. Du has led and participated in several research projects funded by the National Natural Science Foundation of China and local government bodies, showcasing his commitment to scientific advancement and public health improvements.

Areas for Improvement:

While Dr. Du has made remarkable strides in research, further enhancing the interdisciplinary collaboration across different health sectors could strengthen his future projects. Expanding his research into broader, international contexts, and diversifying his focus to include emerging areas in global healthcare trends could also provide additional opportunities for groundbreaking research.

Education:

Dr. Du completed his Master’s Degree in Hospital Management from Flinders University and Nankai University (2012-2014). Prior to this, he earned his Bachelor’s Degree in Clinical Medicine from Kunming Medical University (1988-1992). His strong educational foundation has supported his distinguished career in both medical practice and healthcare administration, particularly in managing complex clinical departments and participating in innovative research efforts in cardiovascular health.

Experience:

Dr. Du has extensive experience at Dali University’s Sixth Affiliated Hospital (Kunming Third People’s Hospital), where he has worked since 1992. Starting as a physician in the Cardiovascular Department, he advanced through roles such as Attending Physician, Deputy Chief Physician, and ultimately Chief Physician. His leadership and expertise have significantly contributed to the hospital’s growth, particularly in the cardiovascular field. Dr. Du has been instrumental in several key research projects, such as optimizing emergency treatment systems for COVID-19 and exploring health disparities in minority populations in Yunnan province.

Research Focus:

Dr. Du’s research focus spans cardiovascular diseases, atherosclerosis, public health, and minority health disparities. He has been involved in multiple National Natural Science Foundation and local government-funded projects. His key research interests include studying the effects of triterpenoid compounds on atherosclerosis and exploring clinical treatment methods for chronic diseases in underserved populations. His work aims to improve healthcare delivery, treatment efficacy, and the cultural competence of medical professionals, especially in minority areas of China.

Publications Top Notes:

  1. Ethnic disparities in the prevalence of chronic non-communicable diseases and its multimorbidity among older adults in rural southwest China 📚🌍
  2. Inflammation markers and the risk of hypertension in people living with HIV 🩺🔥
  3. New cycloartane triterpenes from the roots of Cimicifuga foetida 🌿💡
  4. Omega-6 fatty acids down-regulate matrix metalloproteinase expression in a coronary heart disease-induced rat model 🐀💪

Conclusion:

Dr. Du Yingrong is a highly qualified and dedicated researcher who has made significant contributions to clinical medicine and healthcare research. His leadership in addressing cardiovascular health, minority health disparities, and the COVID-19 pandemic exemplifies his ability to combine clinical expertise with impactful research. He is undoubtedly a strong candidate for the “Best Researcher Award,” with his ongoing contributions to healthcare and public health paving the way for significant improvements in both clinical practice and health system management.

 

 

 

Mai Kadry | Molecular chemistry | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. Mai Kadry | Molecular chemistry | Best Researcher Award

Assist. Prof. Dr. Mai Kadry , National Research Center , Egypt

Mai Osman Mohamed Kadry is a dedicated biochemist, currently working as a researcher in the Therapeutic Chemistry Department at the National Research Centre, Cairo, Egypt. She holds a Doctorate in Biochemistry from Cairo University (2016) and an MSc in Pharmaceutical Sciences from Helwan University (2008). Her primary expertise lies in the field of therapeutic chemistry, with a focus on the biochemical effects of various treatments and their therapeutic potential. In addition to her research, Kadry has academic experience, having taught pharmacognosy at 6 October University. Her work often involves exploring the effects of nanotechnology, antioxidants, and herbal medicines on oxidative stress, toxicity, and cancer treatment. Kadry has contributed significantly to several projects and has published numerous research papers in high-impact journals. She is a well-rounded professional with strong training in various biochemical techniques and computational tools.

Publication Profile:

Scopus

Strengths for the Award:

  1. Academic and Professional Background:
    • Mai Kadry holds a Doctoral degree in Biochemistry, showcasing a high level of academic commitment and specialization. Her focus on cutting-edge research topics such as the amelioration of titanium dioxide-induced oxidative injury, as well as her studies on pharmaceutical and biochemical sciences, highlights her expertise.
    • She has a significant teaching background in the academic field, particularly in the area of pharmacognosy, demonstrating her ability to contribute to the development of future researchers in the field.
  2. Research Output and Publications:
    • Kadry has made substantial contributions to scientific literature, particularly in toxicology and therapeutic chemistry, with numerous research articles published in reputable journals. This includes studies on nano-formulations, the effects of titanium dioxide, and the therapeutic potential of resveratrol.
    • Her involvement in various high-impact research papers underlines her dedication to advancing her field. Additionally, the growing citation of her work further demonstrates the relevance and influence of her research.
  3. Collaboration and Research Initiatives:
    • Kadry has actively participated in multiple innovative research projects at the National Research Centre, focusing on important areas such as nanobiotechnology, hepatocellular carcinoma, and diabetes treatment.
    • Her interdisciplinary approach, involving metabolomics, nanotechnology, and toxicity assessments, shows a broad and comprehensive research capacity, critical for addressing complex health challenges.
  4. Training and Expertise:
    • Kadry has participated in numerous training courses, covering vital techniques like PCR, ELISA, HPLC, and bioinformatics, further strengthening her methodological skills.
    • Her expertise extends to a range of laboratory techniques that are essential for high-quality research in biochemistry and therapeutic chemistry, ensuring the reliability and depth of her scientific investigations.

Areas for Improvement:

  1. Broader Recognition and Networking:
    • While Kadry has published extensively, there could be more emphasis on expanding her research network internationally. Increased participation in global conferences and collaborative research could further elevate her reputation.
  2. Public Outreach and Communication:
    • Enhancing public awareness of her research, possibly through outreach programs or public lectures, could help bridge the gap between scientific research and society. This would make her research more accessible and valuable for a wider audience.
  3. Interdisciplinary Application:
    • While Kadry has shown proficiency in fundamental biochemical research, exploring interdisciplinary applications of her work could bring new insights. For example, connecting her findings to practical medical treatments or developing clinical applications could offer significant real-world value.

Education:

Mai Osman Mohamed Kadry earned her Doctoral degree in Biochemistry from the Faculty of Pharmacy, Cairo University, in 2016, with a dissertation titled “Amelioration Of Nano-sized Titanium Dioxide-Induced Oxidative Injury in Mice by Some Antioxidants.” She holds a Master of Science in Pharmaceutical Sciences from Helwan University (2008), where her research focused on “The Possible Synergistic Role of Phytic and Catechin in Ameliorating the Deteriorative Biochemical Effects Induced By Carbon Tetrachloride in Rats.” Kadry completed her B.Sc. in Pharmaceutical Sciences at Ain Shams University in 2003, graduating with honors and a cumulative grade of Very Good. In addition to her academic qualifications, she has participated in various training courses, including bioinformatics, biosstatistics, scientific typewriting, and protein electrophoresis at the National Research Centre. Her education has provided a robust foundation in pharmaceutical science and biochemistry.

Experience:

Mai Osman Mohamed Kadry has over a decade of academic and research experience in biochemistry and pharmaceutical sciences. She worked as a researcher in the Therapeutic Chemistry Department at the National Research Centre, Cairo, Egypt, where she contributed to multiple research projects related to nanobiotechnology, metabolomics, and the therapeutic efficacy of herbal and chemical entities in treating cancer and diabetes. In her academic career, she taught pharmacognosy at 6 October University (2003-2004) and participated in academic development and quality assurance according to National Commission for Academic Accreditation standards. Kadry’s extensive research experience includes involvement in projects investigating the effects of nanoparticles, herbal medications, and novel chemical compounds on oxidative stress, liver injury, and cancer. She is proficient in a variety of biochemical laboratory techniques, including PCR, ELISA, and HPLC, which have been essential for her research efforts.

Research Focus:

Mai Osman Mohamed Kadry’s research focuses on the biochemical effects of various therapeutic agents, particularly in the areas of nanotechnology, antioxidants, and their role in combating oxidative stress, toxicity, and cancer. Her research aims to explore the potential of nanoparticles, such as titanium dioxide, in ameliorating damage caused by oxidative stress in mice models. She is deeply involved in projects related to the therapeutic properties of herbal medications and chemical entities in treating diseases like liver cancer and diabetes. Kadry is also interested in examining the synergistic effects of natural compounds, such as catechin and phytic acid, in mitigating biochemical damage induced by toxic substances like carbon tetrachloride. Her work further extends to studying autophagy and cell death pathways in response to chemotherapy and other therapeutic agents. Through her research, Kadry seeks to identify novel treatments and biomarkers that can improve the safety and efficacy of therapies for various diseases.

Publications Top Notes:

  1. Titanium nanostructure mitigating doxorubicin–induced testicular toxicity in rats via regulating major autophagy signaling pathways 🧬💉
  2. Inflammatory mediators-induced DNA damage in liver and brain injury: Therapeutic approach of 5-Methoy-N-acetyltryptamine 🧠🩺
  3. Necroptosis and autophagy in cisplatinum-triggered nephrotoxicity: Novel insights regarding their prognostic and diagnostic potential 🩸🔬
  4. Resveratrol-based nano-formulations as an emerging therapeutic strategy for ovarian carcinoma: autophagy stimulation and SIRT-1/Beclin/MMP-9/P53/AKT signaling 💊🌿
  5. miR-122-IGF-1R signaling allied through the dysregulated lncRNA MALAT-1 expression in gastric carcinoma 🍽️🧬
  6. Reciprocal crosslink among MeCP2/BDNF /CREB signaling pinpointed in autism spectrum disorder 🤯🔗
  7. CRISPR-Cas9 genome and long non-coding RNAs as a novel diagnostic index for prostate cancer therapy via liposomal-coated compounds 🧬💉
  8. Collaboration of Hprt/K-RAS/c-Myc mutation in the oncogenesis of T-lymphocytic leukemia: a comparative study 🧬🩺
  9. Thioctic acid shield against lipopolysaccharide depression and endoplasmic reticulum stress: GR7M/Homer/ATF6 signaling 💉🧬
  10. Titanium dioxide nanostructure-loaded Adriamycin surmounts resistance in breast cancer therapy: ABCA/P53/C-myc crosstalk 💪💊

Conclusion:

Mai Osman Mohamed Kadry demonstrates remarkable potential and has made valuable contributions to the fields of biochemistry and therapeutic chemistry. Her academic background, research output, and active involvement in high-impact projects make her a strong contender for the “Best Researcher Award.” While there is room for growth in terms of global outreach and practical applications, her work undoubtedly plays a crucial role in advancing scientific knowledge, particularly in toxicology and the therapeutic use of nanomaterials. Therefore, she is highly deserving of consideration for this prestigious award.

 

 

 

Omer Birkan Agrali | Dentistry | Best Researcher Award

Published on by Cell Biologist

Assoc. Prof. Dr. Omer Birkan Agrali | Dentistry | Best Researcher Award

Assoc. Prof. Dr. Omer Birkan Agrali , Marmara University Faculty of Dentistry, Department of Periodontology , Turkey

Dr. Ömer B. Agrali is an Assistant Professor at Marmara University’s Faculty of Dentistry in the Clinical Sciences Department. His academic journey began at Istanbul University, where he obtained his undergraduate degree in Dentistry in 2005, followed by a doctorate from Marmara University’s Faculty of Dentistry in 2012. With extensive experience in Periodontology, Dr. Agrali has contributed significantly to the field, particularly in areas related to periodontal disease, tissue regeneration, and implantology. He is also active in academic administration, holding numerous positions in committees such as Education and Curriculum, Scientific Research Projects, and Implant Application. Over the years, Dr. Agrali has played an instrumental role in advancing the dental curriculum and overseeing research projects, contributing to the growth of both the faculty and the dental profession in Turkey.

Publication Profile:

Google Scholar

Strengths for the Award:

  1. Expertise and Education: Dr. Agrali holds a Doctorate from Marmara University in Periodontology, one of the most critical areas in dental sciences. His deep academic background and years of experience in both teaching and research reflect a strong foundation in the field.
  2. Research Contributions: Dr. Agrali has an extensive record of published research in reputable journals such as the European Journal of Dentistry and BioMed Research International. His work, particularly on topics like periodontal treatment, bone regeneration, and the impact of various biomaterials, showcases a commitment to advancing dental science. His research is not only abundant but also diverse in scope, covering both clinical and molecular aspects of periodontics.
  3. International Recognition: With publications in international journals, his research reaches a wide academic audience, as evidenced by his significant citations (e.g., articles on bone regeneration and the effectiveness of hyaluronic acid fibers). His international researcher IDs (ScholarID, ORCID, Publons, etc.) further highlight his credibility and recognition in the global academic community.
  4. Academic and Administrative Leadership: As an assistant professor at Marmara University, Dr. Agrali has been actively involved in various administrative and academic committees, shaping curricula and overseeing research project approvals. His leadership roles in several committees, including the Ethics Committee and Implant Application Commission, demonstrate his commitment to maintaining high academic and ethical standards.
  5. Awards and Recognition: Dr. Agrali’s involvement in award-winning projects, such as his contributions to Marmara University’s first International Symposium, reflects his excellence and influence within the academic community.
  6. Teaching Commitment: Dr. Agrali’s long-standing involvement in teaching undergraduate and doctoral courses further establishes his dedication to educating future generations of dental professionals. He is actively involved in both basic courses (Periodontology Clinic, Implantology) and specialized doctorate-level courses.

Areas for Improvement:

  1. Broader Research Network: While Dr. Agrali’s research is substantial, expanding his collaborations internationally, particularly in multidisciplinary areas (such as combining periodontology with other medical or dental specialties), could further elevate his research impact.
  2. Grant Applications and Funding: Although Dr. Agrali has contributed significantly to research, further involvement in large-scale funded research projects and collaborations with industry could enhance his capacity for cutting-edge research and innovation. A more extensive focus on acquiring research grants would strengthen his profile even more.
  3. Public Engagement and Outreach: Increased visibility in popular science and public-facing platforms could make his work more accessible to non-academic audiences. Public health campaigns or collaborations with organizations promoting oral health would amplify the practical application of his findings.

Education:

Dr. Ömer B. Agrali completed his undergraduate studies in Dentistry at Istanbul University’s Faculty of Dentistry, graduating in 2005. He then pursued a doctorate at Marmara University’s Faculty of Dentistry, specializing in Periodontology, and earned his degree in 2012. His doctoral research focused on evaluating the levels of growth factors and alkaline phosphatase in gingival crevicular fluid of patients with periodontal defects treated with enamel matrix derivatives and autogenous bone grafts. Throughout his academic career, Dr. Agrali has continuously expanded his knowledge and expertise, focusing on clinical aspects of periodontal disease, bone regeneration, and implantology. He is also proficient in English at a B2 Upper-Intermediate level, enhancing his ability to engage in international research and academic collaboration. Dr. Agrali’s educational foundation laid the groundwork for his continuing contributions to dental science and education.

Experience:

Dr. Ömer B. Agrali has extensive academic and administrative experience at Marmara University’s Faculty of Dentistry. He joined the faculty as a Research Assistant in 2011 and quickly progressed to the role of Assistant Professor in 2013. Over the years, he has held significant administrative roles, including Deputy Head of Department from 2018-2019, as well as memberships in numerous committees, such as the Education and Curriculum Committee, Scientific Research Projects Acceptance Committee, and the Implant Application Commission. His academic involvement extends to teaching undergraduate and doctoral students, specializing in periodontology, implantology, and advanced dental treatment techniques. Additionally, Dr. Agrali has served on various jury panels for doctoral examinations and has actively participated in curriculum development. His professional experience in both academic and clinical settings makes him a valuable member of the Faculty of Dentistry, contributing significantly to its research, education, and overall growth.

Awards and Honors:

Dr. Ömer B. Agrali’s career has been marked by recognition and awards for his contributions to dental science and education. Notably, he received the Poster First Prize at Marmara University’s Faculty of Dentistry’s 1st International Symposium in May 2018, a testament to his innovative research and presentation skills. Furthermore, in January 2018, he was honored with the National Publication Award by Marmara University’s Health Sciences Institute for his research publications in the field of periodontology. These awards reflect Dr. Agrali’s commitment to advancing dental knowledge and his reputation as an outstanding researcher. His passion for teaching and research has earned him respect and recognition among his colleagues and students, further reinforcing his position as a leader in his field. His academic achievements highlight his dedication to promoting scientific inquiry and improving the standard of dental care.

Research Focus:

Dr. Ömer B. Agrali’s primary research interests lie in the field of Periodontology, with a focus on periodontal disease, tissue regeneration, and implantology. His doctoral research explored the effects of enamel matrix derivatives and autogenous bone grafts on periodontal defects, specifically examining the levels of transforming growth factor-ß1 and alkaline phosphatase in gingival crevicular fluid. Dr. Agrali is also interested in exploring the biological mechanisms behind tissue healing and regeneration, particularly in relation to bone regeneration and implant success. In addition to his clinical research, he has contributed to studies examining the efficacy of various treatment modalities for conditions such as peri-implantitis and lateral periodontal cysts. His research extends into nanobiomaterials and drug delivery systems in dental applications. Through his work, Dr. Agrali strives to enhance clinical outcomes in periodontology and improve patient care, contributing to advancements in both basic and applied dental sciences.

Publications Top Notes:

  • Periodontal treatment in a generalized severe chronic periodontitis patient: A case report with 7-year follow-up 🦷
  • Peri-implantitis and Severity Level 🦷
  • Treatment of lateral periodontal cyst with guided tissue regeneration 🦷
  • Evaluation of the effectiveness of esterified hyaluronic acid fibers on bone regeneration in rat calvarial defects 🧬
  • Evaluation of gingival crevicular fluid transforming growth factor-[beta] 1 level after treatment of intrabony periodontal defects with enamel matrix derivatives and autogenous bone grafts 🦷
  • Nanobiomaterials in dentistry: Applications of nanobiomaterials 🧪
  • Drug delivery systems for dental applications 💊
  • The gingival crevicular fluid levels of growth factors in patients with amlodipine-induced gingival overgrowth: A pilot study 🦷
  • Cytotoxicity of different nano composite resins on human gingival and periodontal ligament fibroblast cell lines: an in vitro study 🧬
  • Cytotoxicity and collagen expression effects of Tideglusib administration on human periodontal cells: an In-vitro study 🧪

Conclusion:

Dr. Ömer Agrali is a highly deserving candidate for the “Best Researcher Award.” His extensive research output, leadership in academia, contributions to scientific advancements in periodontology, and recognition within the academic community make him an excellent choice for this honor. To further strengthen his profile, expanding international collaborations and engaging with a broader research network would be beneficial. Overall, Dr. Agrali’s work is a valuable asset to the field of periodontology, and he continues to make significant contributions to dental science and education.

 

 

 

Tao | PDT | Best Researcher Award

Published on by Cell Biologist

Dr. Tao | PDT | Best Researcher Award 

Dr. Tao , Guangxi Uni , China

Professor Tao Liu is a distinguished researcher and professor at the School of Resources, Environment, and Materials at Guangxi University. He is a doctoral supervisor and a specially-appointed expert of the China Association for Science and Technology’s Overseas Talent Plan. With a focus on organic optoelectronic materials, his work spans perovskite solar cells, luminescence, and photocatalysts. He has made significant contributions to environmental science through his research on removing organic pollutants and heavy metal ions from wastewater. Professor Liu has published over 126 SCI papers in prestigious journals, with over 11,300 citations. He is internationally recognized for his expertise in materials science and has served as an expert for various scientific committees, think tanks, and industrial initiatives. His accomplishments have earned him recognition as a highly cited scholar and one of the top global scientists.

Publication Profile:

Scopus

Strengths for the Award:

Professor Tao Liu has demonstrated outstanding achievements in the field of organic optoelectronic materials, especially in perovskite solar cells, photocatalysis, and water purification. His contributions are highly recognized globally, with over 126 SCI papers published in prestigious journals like Nat. Energy and Energy Environ. Sci., with more than 11,300 citations and an h-index of 57. His pioneering work in sustainable materials, like biochar photocatalysts for wastewater treatment, showcases his commitment to environmental innovation. He has been repeatedly honored as a “Highly Cited Scholar” and ranks among the top 2% of global scientists, reflecting his influence in materials science.

Areas for Improvements:

Despite his numerous accolades, there is potential for further cross-disciplinary collaboration to strengthen the integration of his work with industrial applications. Expanding his outreach into new, less explored areas of environmental science could enhance the global impact of his research.

Education:

Professor Tao Liu completed his education in materials science, earning his doctoral degree with a focus on organic functional materials and optoelectronics. He gained advanced training in interdisciplinary fields, particularly in photocatalysis and materials engineering. Liu’s academic journey also involved significant postdoctoral research, focusing on material applications for energy and environmental sustainability. His research contributions have positioned him as a leading expert in his field, influencing advancements in organic materials and renewable energy technologies. His robust education foundation, coupled with a passion for innovation, has greatly shaped his ability to lead groundbreaking research and provide mentorship to students and researchers alike.

Experience:

Professor Liu has extensive research experience, contributing significantly to materials science, particularly organic optoelectronic materials and their applications in energy, environment, and wastewater treatment. He has held multiple roles as an expert reviewer, consultant, and committee member for various scientific organizations, including the China Rare Earth Society and the Guangxi Ecological Civilization Construction Demonstration Zone. His research experience spans across academic institutions and industrial projects, where he has collaborated with top-tier researchers globally. Professor Liu has been instrumental in advancing environmental solutions, particularly in the removal of pollutants through innovative photocatalytic materials, which has earned him widespread recognition and numerous accolades in his field.

Awards and Honors:

Professor Tao Liu has received numerous prestigious awards and honors for his groundbreaking research. He has been named a “Highly Cited Scholar” by Clarivate for three consecutive years (2020-2022) and ranked among the top 2% of scientists globally for four years in a row. Liu has been recognized for his highly impactful publications, receiving multiple selections for ESI Hot Papers and Highly Cited Papers. His contributions to materials science have earned him distinctions, including the 2022 Science Nova Award and the Cell Press Chinese Scientist Best Paper Award. Liu’s achievements also include high rankings in global academic influence and recognition for his exceptional scientific papers published in top-tier journals.

Research Focus:

Professor Liu’s research focus is on organic optoelectronic materials, particularly their applications in solar cells, photocatalysis, and environmental cleanup. His work in perovskite solar cells, photocatalysts for organic pollutant removal, and wastewater treatment has been transformative in the materials science community. Liu has developed innovative materials for efficient energy conversion and environmental remediation, aiming to tackle global challenges related to pollution and energy sustainability. His research also explores advanced organic semiconductors and their integration into systems for environmental and energy applications. His contributions aim to create sustainable technologies that address both energy production and pollution control simultaneously.

Publications Top Notes:

  • An innovative eco-friendly organic semiconductor-biochar photocatalytic adsorbent for efficient and stable removal mechanism of oxytetracycline hydrochloride under light illumination
  • Investigation of fullerene and non-fullerene materials in organic photocatalysts on the efficiency of photocatalytic degradation of polychlorinated biphenyls
  • A high-efficiency clay mineral based organic photocatalyst towards photodegradation of butyl xanthate in mineral processing wastewater
  • D/A heterojunction photocatalysts interspersed onto biochar to couple photocatalysis and adsorption for visible light-responsive efficient removal of pollutants
  • Efficient photodegradation of carbamazepine by organocatalysts incorporating a third component with a more complementary absorption spectrum
  • Heterojunction lithiation engineering and diffusion-induced defect passivation for highly efficient Sb2(S,Se)3 solar cells
  • Modulation of crystallization kinetics using a guest acceptor for high-performance organic solar cells with 19.8% efficiency
  • A novel design of copper selenide/zinc selenide/Nitrogen-doped carbon derived from MOF for sulfadiazine adsorption: Performance and mechanism
  • An organic visible-photocatalytic-adsorbence mechanism to high-efficient removal of heavy metal antimony ions
  • A Novel Non-Fullerene D-A Interface with Two Asymmetrical Electron Acceptors Facilitates Charge and Energy Transfer for Effective Carbon Dioxide Reduction

Conclusion:

With his exceptional publication record, international recognition, and continuous contribution to advancing materials science and environmental sustainability, Professor Tao Liu is undoubtedly a strong candidate for the Best Researcher Award. His innovative work in photocatalysis and optoelectronics not only addresses key scientific challenges but also contributes to global ecological solutions.

 

 

 

 

Hatice Yesim Karasulu | Cellular Microenvironment Interactions | Excellence in Research

Published on by Cell Biologist

Prof. Dr. Hatice Yesim Karasulu | Cellular Microenvironment Interactions | Excellence in Research

Prof. Dr. Hatice Yesim Karasulu , Ege University , Turkey

Prof. Dr. H. Yesim Karasulu is a distinguished academician in the field of pharmaceutical technology, currently serving as a Professor in the Department of Pharmaceutical Technology at Ege University, Faculty of Pharmacy, Turkey. She completed her Ph.D. at Ege University and advanced to Associate Professor in 2006 and Professor in 2011. Her work as a consultant at Ege University’s ARGEFAR since 2011 and her contributions to the Turkish Ministry of Health’s Pharmaceutical and Medical Devices Agency (2006–2024) underscore her significant impact on both academia and industry. She has collaborated on international research and development projects, and her achievements include patents and international grant-funded projects. Prof. Karasulu has published over 50 scientific papers and delivered numerous oral and poster presentations. Her expertise spans pharmaceutical formulations, drug delivery systems, and biopharmaceutics, positioning her as a leader in her field.

Publication Profile:

Google Scholar

Strengths for the Award:

Prof. Dr. H. Yeşim Karasulu is a highly accomplished and influential researcher in the field of pharmaceutical technology. With more than 50 publications, including articles in top journals and book chapters, she has demonstrated a deep commitment to advancing pharmaceutical research, particularly in the area of drug delivery systems. Her pioneering work on colloidal drug delivery systems such as liposomes, nano/microparticles, and SEDDS has had significant implications for drug development. Her collaboration with both academic institutions and the pharmaceutical industry, leading to patents and commercial products under pharmaceutical license, highlights the practical impact of her work. Additionally, her extensive involvement in research projects funded at national and international levels, as well as her leadership roles, showcases her ability to drive innovation and contribute to the scientific community.

Areas for Improvement:

While Prof. Dr. Karasulu has made remarkable contributions, continuing to build collaborative networks with global research institutions and fostering interdisciplinary research could help broaden the impact of her findings. Enhancing visibility in high-impact international conferences or fostering collaborations in underexplored regions might allow her work to reach new audiences, ensuring that her innovations in drug delivery systems are applied more widely across different health sectors.

Education:

Prof. Dr. H. Yesim Karasulu earned her Ph.D. in Pharmaceutical Technology from Ege University, Faculty of Pharmacy, where she also completed her undergraduate studies. Her academic journey includes post-doctoral research at the University of Vienna, Department of Pharmaceutical Technology and Biopharmaceutics, working under Prof. Dr. Franz Gabor. Prof. Karasulu’s comprehensive education laid a strong foundation for her pioneering research in the field of drug delivery systems. Her work has been recognized both nationally and internationally, as evidenced by her academic promotions and various prestigious grants. She has also contributed to the development of new pharmaceutical technologies, and her research has influenced both educational and professional practices in the pharmaceutical industry. Prof. Karasulu’s educational journey is marked by continuous development and contributions to advancing pharmaceutical sciences, which is reflected in her ongoing academic and consulting roles.

Experience:

Prof. Dr. H. Yesim Karasulu has a rich professional background in pharmaceutical sciences. After earning her Ph.D., she quickly advanced in academia, being promoted to Associate Professor in 2006 and Professor in 2011. Alongside her academic career, Prof. Karasulu has served as a consultant at Ege University’s ARGEFAR, contributing to the development of innovative drug delivery systems and pharmaceutical technologies. Her extensive experience in the pharmaceutical sector includes her role as a member of the Pharmaceutical Technology Commission at the Turkish Ministry of Health’s Pharmaceuticals and Medical Devices Agency from 2006 to 2024. Prof. Karasulu has also conducted post-doctoral research in Vienna, enhancing her expertise in drug delivery and biopharmaceutics. Her broad range of experiences has led to successful collaborations with both the academic and industrial sectors, resulting in patent applications and new pharmaceutical products, further highlighting her significant contributions to the field of pharmaceutical technology and drug delivery.

Research Focus:

Prof. Dr. H. Yesim Karasulu’s research focuses on the development, characterization, and evaluation of advanced drug delivery systems, particularly colloidal systems such as liposomes, nanoparticles, microemulsions, and self-emulsifying drug delivery systems (SEDDS). Her work aims to enhance the efficacy, stability, and bioavailability of pharmaceuticals, particularly through non-invasive routes like transdermal, nasal, and vaginal delivery. Prof. Karasulu is particularly interested in the physicochemical properties that govern drug absorption and permeation, conducting numerous studies on skin permeation, mucosal delivery, and targeted drug delivery to various organs. Her research is driven by a strong desire to bridge the gap between basic pharmaceutical technology and real-world clinical applications. She has contributed significantly to the scientific understanding of drug release mechanisms and the potential of microemulsions as novel carriers for active pharmaceutical ingredients. Prof. Karasulu’s work has been supported by numerous grants and has led to the development of several patents and ongoing product innovations in the pharmaceutical industry.

Publications Top Notes:

  1. Transdermal delivery of diclofenac sodium through rat skin from various formulations 📄💊
  2. Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations 🌿💉
  3. Microemulsions as novel drug carriers: the formation, stability, applications and toxicity 🔬⚗️
  4. Comparison of different water/oil microemulsions containing diclofenac sodium: preparation, characterization, release rate, and skin irritation studies 💧💊
  5. Extended release lipophilic indomethacin microspheres: formulation factors and mathematical equations fitted drug release rates 📊💉
  6. Modeling of theophylline release from different geometrical erodible tablets 🧬📖
  7. Efficacy of a new ketoconazole bioadhesive vaginal tablet on Candida albicans 🦠💊
  8. Permeation studies and histological examination of sheep nasal mucosa following administration of different nasal formulations with or without absorption enhancers 🐑👃
  9. Synthesis, molecular modeling, in vivo study, and anticancer activity of 1,2,4‐triazole containing hydrazide–hydrazones derived from (S)‐naproxen 💡🔬
  10. Preparation and evaluation of novel microemulsion-based hydrogels for dermal delivery of benzocaine 💧🧴

Conclusion:

Prof. Dr. H. Yeşim Karasulu is an exemplary candidate for the Excellence in Research award due to her consistent and impactful contributions to pharmaceutical research. Her work has led to significant advancements in drug delivery systems, evidenced by her substantial publication record, patents, and collaborations. Her achievements place her at the forefront of pharmaceutical technology and innovation, making her well-deserving of this recognition.

 

 

 

 

Fouaz Lekoui | Antibacterial surfaces | Excellence in Research

Published on by Cell Biologist

Dr. Fouaz Lekoui | Antibacterial surfaces | Excellence in Research

Dr. Fouaz Lekoui , Centre de développement des technologies avancées (CDTA) , Algeria

Dr. Fouaz Lekoui, born on July 23, 1985, in Collo, Algeria, is an accomplished researcher with over 10 years of experience in materials science and thin films deposition. He is currently working at the Center for Development of Advanced Technologies (CDTA) in Algiers, where he leads research on PVD, CVD techniques, and thin-film characterization. With a strong background in mechanical engineering, he has contributed significantly to the advancement of transparent, conductive, and antibacterial materials. His academic career includes teaching at several prestigious universities and supervising numerous Master’s and PhD theses. Dr. Lekoui’s research has led to multiple high-impact publications and collaborative projects, showcasing his expertise in functional thin films and surface characterization.

Publication Profile:

Orcid

Strengths for the Award:

  1. Extensive Research Experience:
    • Fouaz Lekoui has over a decade of research experience in thin film deposition, particularly in PVD and CVD techniques. His deep expertise includes thin film elaboration, characterization, and a strong background in advanced technologies such as annealing and diffusion furnaces. This extensive experience in a highly specialized field is a notable strength for recognition in research excellence.
  2. High-Impact Contributions to Scientific Literature:
    • Lekoui has contributed to a significant number of peer-reviewed journal articles and book chapters. His recent publications include cutting-edge studies on the structural, optical, and electrical properties of multifunctional thin films, such as ZnO-Ag and ZnO-Mg thin films, which are of great interest for applications in transparent conductive and antibacterial materials.
    • Notable works, including his article in Inorganic Chemistry Communications (2024) and Journal of Ovonic Research (2024), showcase his leadership in advanced materials science, especially in the context of nanomaterials and thin film technologies.
  3. Academic and Professional Leadership:
    • As an associate professor with a wide teaching range at various esteemed institutions (Algiers 1 University, Military Materials School), Lekoui has made significant contributions to academia by training the next generation of scientists and engineers.
    • He has supervised or co-supervised numerous master’s and PhD theses, further emphasizing his mentoring capabilities in scientific research.
  4. Leadership in Conferences and Seminars:
    • Chairman of the First Seminar on Materials, Processes, and Microfabrication (2024), Lekoui has demonstrated excellent leadership in organizing and advancing scientific dialogues in his field.
  5. Multidisciplinary Expertise:
    • His work spans across several key areas in material science, including semiconductor materials, biophysics, and energy-efficient technologies, making him a highly versatile researcher.
  6. International Collaboration and Recognition:
    • Lekoui’s collaborations extend to researchers and institutions across the globe, indicating the international recognition and impact of his research. His involvement in multiple journal articles with notable contributions shows his ability to work in diverse research teams.

Areas for Improvement:

  1. Broader Public Engagement and Outreach:
    • While Lekoui’s research impact is significant within academic and professional circles, broader outreach, such as public lectures, popular science writing, or media engagement, could help elevate his visibility and the societal impact of his research.
  2. Diversification of Research Focus:
    • Although Lekoui has shown substantial depth in his field of expertise, exploring adjacent fields such as sustainable materials, energy storage, or quantum materials could enhance his research profile and broaden his contributions to modern technological needs.
  3. Grant and Project Leadership:
    • While Lekoui is involved in collaborative research, taking a leading role in high-profile research projects and securing major research grants could further solidify his standing in the international scientific community.

Education:

Dr. Fouaz Lekoui holds a diverse academic background. He completed his Baccalaureate in Exact Sciences in 2003, followed by an Engineer degree in Mechanical Engineering (Energy Option) in 2009, where he acquired knowledge in thermodynamics, propulsion mechanics, and fluid mechanics. In 2012, he obtained his Magister in Mechanical Engineering specializing in materials and surfaces, with a thesis on phosphomagnesian cement. Dr. Lekoui then completed his PhD in Mechanical Engineering in 2019, focusing on functional thin films based on Zn-Ag-Mg-O systems. In 2022, he received his HDR (Habilitation to Direct Research) in Mechanical Engineering, specializing in materials science, cementing his expertise in materials and surfaces.

Experience:

Dr. Lekoui’s professional journey spans both academic and research roles. Since 2013, he has been a researcher at CDTA, contributing to thin-film deposition and advanced surface characterization. He specializes in evaporation, sputtering DC magnetron techniques, and ultra-high vacuum technologies. His internships at Sonatrach and Bazoul w. power station further enriched his practical experience. As an associate professor, he taught at Ben Youcef Benkhedda University, Algiers 1 University, and the Military Materials School, imparting knowledge in materials science, physics, optics, and nanotechnology. He has supervised 19 Master’s theses and co-supervised multiple PhD projects, demonstrating his commitment to academic mentorship.

Research Focus:

Dr. Lekoui’s research primarily revolves around the elaboration and characterization of functional thin films, with a focus on transparent, conductive, and antibacterial materials. His work investigates ZnO-based thin films doped with silver, magnesium, and manganese, exploring their optical, electrical, and structural properties. He has also explored nano-materials, vacuum deposition techniques, and surface treatments such as oxidation and annealing. Dr. Lekoui is passionate about developing innovative materials for applications in optics, photonics, and renewable energy, contributing to various interdisciplinary fields such as nanotechnology, biophysics, and semiconductor technologies.

Publications Top Notes:

  • Optical parameters extraction of zinc oxide thin films doped with manganese using an innovative technique based on the dragonfly algorithm and their correlation to the structural properties 🦋📚
  • Studying the Effect of Mn Doping on the Electrical and Optical Properties of ZnO/Ag/ZnO Multilayer 🔬⚡
  • Ag-Doped ZnO nanostructured thin films for transparent antibacterial surfaces: Effect of Ag content 💧🦠
  • Investigation structural heterogeneities in hydrogenated nanocrystalline silicon thin films from argon-diluted silane dusty plasma PECVD ⚙️🌐
  • Machine learning-based method for predicting C–V-T characteristics and electrical parameters of GaAs/AlGaAs multi-quantum wells Schottky diodes 💻📊
  • Structural and optical properties of highly Ag-doped TiO2 thin films prepared by flash thermal evaporation 🔥🖤
  • Effect of Ti/TiN Thin Film Geometrical Design on the Response of RTDs 🧪📐
  • Electrical Parameters Extraction of Diode Using Whale Optimization Algorithm 🐋🔧
  • On the substrate heating effects on structural, mechanical and linear/non-linear optical properties of Ag–Mn co-doped ZnO thin films 🔥🔬

Conclusion:

Fouaz Lekoui’s research portfolio demonstrates a profound commitment to advancing materials science, particularly in the domain of thin films and nanotechnology. His significant contributions to high-impact research, strong academic and professional leadership, and proven mentoring ability underscore his suitability for a Research Excellence Award. The areas for improvement are relatively minor in comparison to his established strengths, and addressing them could further enhance his impact in both scientific and public domains. Thus, based on his accomplishments, he is highly deserving of the recognition in the Research for Excellence in Research category.